Maastricht UMC+ and Maastricht University serve as the lead coordinating healthcare centre, while the Netherlands Cancer Institute acts as a key scientific partner. Together, the organisations contribute clinical, organisational and research expertise to support the project’s focus on the safe and practical implementation of AI in hospitals.
COMPASS-AI aims to connect healthcare professionals, hospital leaders, IT specialists, industry partners, policymakers and patient representatives to develop guidance for trustworthy and transparent AI adoption in clinical settings. The European Commission has designated COMPASS-AI as a cornerstone project within the APPLY AI strategy, highlighting the value of collaboration between medical, technological and scientific institutions.
The European Commission emphasises the potential of AI to improve early diagnosis, treatment decisions and workflow efficiency. In a recent statement, EU Commissioner Olivér Várhelyi noted that projects like COMPASS-AI play an important role in ensuring that reliable AI innovations reach clinical practice responsibly and at scale.
According to project coordinator Prof. Regina Beets-Tan, the strong collaboration between MUMC+, Maastricht University and the Netherlands Cancer Institute provides a solid foundation for developing AI solutions that can enhance patient care across Europe.
Read also
